Company intelligence / Profile preview

VividWhite

Melbourne, Victoria, Australiavividwhite.com.au ↗

Ownership: Private
Development stage: Phase 1

Overview

VividWhite is a private Australian medical device company focused on developing novel microfluidic surgical implants for the treatment of glaucoma. Its lead product is in human clinical trials, with a 10-participant safety/performance study completed and a larger 65-participant multi-centre registration study planned. The company has also received $1 million in funding from the Clinical Translation and Commercialisation Medtech program to support manufacturing scale-up and further clinical studies.

Therapeutic areas: Ophthalmology
Modalities: DeviceMicrofluidic surgical implant
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on VividWhite.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VividWhite.

Explore the full profile